... Infected Individuals in Guinea-Bissau, West Africa — Archives of Internal Medicine
Viral Load — International Association of Providers of AIDS Care
About HIV — Centers for Disease Control and Prevention
HIV-2 Infection — National HIV Curriculum
HIV Testing — Centers for Disease Control and Prevention
HIV Treatment — HIVinfo.NIH.gov
Antiretroviral Treatment ...
VIH-1 frente a VIH-2: ¿Cuáles son las diferencias y puede tener ambas?
... Infected Individuals in Guinea-Bissau, West Africa — Archives of Internal Medicine
Viral Load — International Association of Providers of AIDS Care
About HIV — Centers for Disease Control and Prevention
HIV-2 Infection — National HIV Curriculum
HIV Testing — Centers for Disease Control and Prevention
HIV Treatment — HIVinfo.NIH.gov
Antiretroviral Treatment ...
... Referencias
Immune Reconstitution Inflammatory Syndrome — StatPearls
HIV Treatment and Care — Centers for Disease Control and Prevention
Highly Active Anti-Retroviral Therapy (HAART) — Steps for Living
Management of Immune Reconstitution Inflammatory Syndrome (IRIS) — Clinical Guidelines Program
Guidelines for the Use of Antiretroviral Agents in Adults ...
El SIRI en el VIH: 7 datos que debe conocer
... Referencias
Immune Reconstitution Inflammatory Syndrome — StatPearls
HIV Treatment and Care — Centers for Disease Control and Prevention
Highly Active Anti-Retroviral Therapy (HAART) — Steps for Living
Management of Immune Reconstitution Inflammatory Syndrome (IRIS) — Clinical Guidelines Program
Guidelines for the Use of Antiretroviral Agents in Adults ...
... un régimen inicial para el tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents ...
Resistencia farmacológica al VIH: Mutaciones, pruebas, síntomas, y más
... un régimen inicial para el tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents ...
... Aidsmap
Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008-2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral ...
Envejecer con VIH: 5 problemas que debe vigilar
... Aidsmap
Population-Based Estimates of Life Expectancy After HIV Diagnosis: United States 2008-2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral ...
... El diagnóstico temprano es esencial ya que permite iniciar el tratamiento del VIH con la terapia antirretroviral (TAR), que ayuda a disminuir la carga viral y reducir el riesgo de transmitir el virus, al igual que ayuda a mejorar los síntomas de la infección aguda.Recibir atención médica temprana ayuda a vigilar cómo avanza la infección y a detectar ...
¿Cómo reconocer el VIH? 9 primeros síntomas
... El diagnóstico temprano es esencial ya que permite iniciar el tratamiento del VIH con la terapia antirretroviral (TAR), que ayuda a disminuir la carga viral y reducir el riesgo de transmitir el virus, al igual que ayuda a mejorar los síntomas de la infección aguda.Recibir atención médica temprana ayuda a vigilar cómo avanza la infección y a detectar ...
... FDA Approves Gilead’s Long-Acting HIV Drug Sunlenca — Reuters
Sunlenca — European Medicines Agency
Treating HIV — Centers for Disease Control and Prevention
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — ClinicalInfo.HIV.gov
Vaccinations for Adults With HIV Infection — Immunize.org
HIV and AIDS and Mental Health ...
Tratamientos para el VIH
... FDA Approves Gilead’s Long-Acting HIV Drug Sunlenca — Reuters
Sunlenca — European Medicines Agency
Treating HIV — Centers for Disease Control and Prevention
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV — ClinicalInfo.HIV.gov
Vaccinations for Adults With HIV Infection — Immunize.org
HIV and AIDS and Mental Health ...
... in the United States — Current Medical Research and Opinion
HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.gov
Weight Changes, Metabolic Syndrome and All-Cause Mortality Among Asian Adults Living With HIV — HIV Medicine
Weight Gain — International Association of Providers of AIDS Care
Aging ...
4 causas de aumento de peso con el VIH
... in the United States — Current Medical Research and Opinion
HIV-Related Immune Activation May Predict Weight Gain and Exacerbate Complications, Especially in Women — HIV.gov
Weight Changes, Metabolic Syndrome and All-Cause Mortality Among Asian Adults Living With HIV — HIV Medicine
Weight Gain — International Association of Providers of AIDS Care
Aging ...
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
¿Se puede contagiar el VIH al compartir bebidas o besarse?
... — HIV.gov
Management of Health Care Personnel Exposed to HIV — Wolters Kluwer UpToDate
Preguntas frecuentes con relación al VIH y el sida — ONUSIDA
Harm Reduction To Lessen HIV Risks — National Institute of Allergy and Infectious Diseases
Profilaxis posexposición (PEP) — HIVinfo
Prueba de carga viral — MedlinePlus
...
... El rebote viral fue poco frecuente en ambos grupos (de nuevo, en alrededor del 1 por ciento).
¿Hubo efectos secundarios?En general, los efectos secundarios fueron parecidos a los observados con otros tratamientos contra el VIH, y la mayoría fueron leves o moderados. ...
... Además, la terapia antirretroviral disminuye y controla la carga viral, eliminando prácticamente el riesgo de transmisión. “Si tienes carga viral indetectable es muy difícil transmitirlo, ¡incluso puedes tener un bebé!” comentó un miembro de myHIVteam. ...
únete
